+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Latin America Flow Cytometry Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Technology, By Application (Research, Industrial), By End-use, By Country, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 102 Pages
  • October 2023
  • Region: Latin America
  • Grand View Research
  • ID: 5899512
The Latin America flow cytometry market size is expected to reach USD 556.21 million by 2030, expanding at a CAGR of 6.44% from 2023 to 2030. The rising prevalence of target diseases, including cancer, infectious diseases, and immunodeficiency disorders, is driving the growth of the market. According to the American Cancer Society an estimated 1.3 million new cancer cases are found in Latin America, leading to the death of 666,000 people in the region.

Flow cytometry helps provide rapid and accurate analysis of cells and particles, enabling its rapid adoption for diagnostic purposes. The growing need for precise diagnostics and personalized medicine is driving the Latin America flow cytometry market. Moreover, a number of players in Latin America are focusing on providing technological advancements, including developing high-throughput f systems, improved reagents, and integrating artificial intelligence and machine learning for data analysis to meet the rising demand for rapid diagnostics in the region. For instance, in November 2022, Bio-Rad Laboratories, Inc. announced the launch of three StarBright Dyes, including StarBright Violet 440, StarBright Blue 700, and StarBright Violet 610 that are specifically being developed to be used for flow cytometry. These dyes help in providing an improved resolution and maximal brightness.

Moreover, the use of flow cytometry in stem cell research is experiencing a rising trend, and its applications in clinical research are expanding unprecedently. For instance, in April 2022 the International Journal of Laboratory Hematology highlighted the versatility of this technique employed to analyze the attributes of heterogeneous cell populations derived from peripheral blood (PB), bone marrow (BM), and fragmented solid tissues, enabling subsequent in-depth investigations. Consequently, the utilization of flow cytometry in these areas is propelling the advancement of the investigated market.

Furthermore, key players involved in developing and formulating various technologies are focusing on collaborations and partnerships to develop novel instruments and maintain their competitive position in the market. For instance, in June 2022, BD (Becton, Dickinson and Company) announced the launch of an advanced system that works on the system of sorting cells based on their internal workings. Moreover, in March 2022, Beckman Coulter Life Sciences announced the launch of CellMek SPS, an automated system used in clinical flow cytometry for sample preparation.

Latin America Flow Cytometry Market Report Highlights

  • Based on product, the instrument segment held the largest revenue share of the market in 2022 owing to rising technological advancement and higher penetration
  • Based on technology, the bead-based technology segment is expected to show the fastest growth rate over the forecast period owing to the ability of the technology to measure various proteins
  • On the basis of application, the clinical segment dominated the Latin America flow cytometry market in 2022 due to the rising prevalence of various target diseases
  • On the basis of end-use, the clinical testing labs segment dominated the Latin America flow cytometry market in 2022 due to the rising R&D in the development of diagnostics in the market
  • Key players operating in the market are constantly focusing on product launches and geographical expansion to maintain their presence

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Formulation & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objective
1.9.1. Objective 1
1.9.2. Objective2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of chronic and infectious diseases
3.2.1.2. High R&D investments in biotechnology, clinical, and life sciences research
3.2.1.3. Technological advancement in flow cytometry instruments and reagents
3.2.1.4. Increasing demand for point-of-care diagnostics
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of instruments
3.2.3. Market Challenges Analysis
3.2.3.1. Low cell throughput rate
3.3. SWOT Analysis, by Factor
3.4. Industry Analysis - Porter’s
3.5. Regulatory & Reimbursement Scenario
3.6. Pricing Analysis
3.7. Trade Data
3.7.1. Import/Export data for flow cytometers
3.8. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Latin America Flow Cytometry Market: Product Movement Analysis
4.2. Instruments
4.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.2.2. Cell Analysers
4.2.2.1. Cell Analysers Market, 2018 - 2030 (USD Million)
4.2.3. Cell Sorters
4.2.3.1. Cell Sorters Market, 2018 - 2030 (USD Million)
4.3. Reagents & Consumables
4.3.1. Reagents & Consumables Market, 2018 - 2030 (USD Million)
4.4. Software
4.4.1. Software Market, 2018 - 2030 (USD Million)
4.5. Accessories
4.5.1. Accessories Market, 2018 - 2030 (USD Million)
4.6. Services
4.6.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. Technology Business Analysis
5.1. Latin America Flow Cytometry Market: Technology Movement Analysis
5.2. Cell-Based
5.2.1. Cell-Based Market, 2018 - 2030 (USD Million)
5.3. Bead-Based
5.3.1. Bead-Based Market, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. Latin America Flow Cytometry Market: Application Movement Analysis
6.2. Research
6.2.1. Research Market, 2018 - 2030 (USD Million)
6.2.2. Pharmaceutical
6.2.2.1. Pharmaceutical Market, 2018 - 2030 (USD Million)
6.2.2.2. Drug Discovery
6.2.2.3. Drug Discovery Market, 2018 - 2030 (USD Million)
6.2.2.4. Stem Cell
6.2.2.5. Stem Cell Market, 2018 - 2030 (USD Million)
6.2.2.6. In-Vitro Toxicity
6.2.2.7. InVitro Toxicity Market, 2018 - 2030 (USD Million)
6.2.3. Apoptosis
6.2.3.1. Apoptosis Market, 2018 - 2030 (USD Million)
6.2.4. Cell Sorting
6.2.4.1. Cell Sorting Market, 2018 - 2030 (USD Million)
6.2.5. Cell Cycle Analyser
6.2.5.1. Cell Cycle Analyser Market, 2018 - 2030 (USD Million)
6.2.6. Immunology
6.2.6.1. Immunology Market, 2018 - 2030 (USD Million)
6.2.7. Cell Viability
6.2.7.1. Cell Viability Market, 2018 - 2030 (USD Million)
6.3. Industrial
6.3.1. Industrial Market, 2018 - 2030 (USD Million)
6.4. Clinical
6.4.1. Clinical Market, 2018 - 2030 (USD Million)
6.4.2. Cancer
6.4.2.1. Cancer Market, 2018 - 2030 (USD Million)
6.4.3. Organ Transplantation
6.4.3.1. Organ Transplantation Market, 2018 - 2030 (USD Million)
6.4.4. Immunodeficiency
6.4.4.1. Immunodeficiency Market, 2018 - 2030 (USD Million)
6.4.5. Hematology
6.4.5.1. Hematology Market, 2018 - 2030 (USD Million)
Chapter 7. End-Use Business Analysis
7.1. Latin America Flow Cytometry Market: End-Use Movement Analysis
7.2. Commercial Organizations
7.2.1. Commercial Organizations Market, 2018 - 2030 (USD Million)
7.2.2. Biotechnology Companies
7.2.2.1. Biotechnology Companies Market, 2018 - 2030 (USD Million)
7.2.3. Pharmaceutical Companies
7.2.3.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
7.2.4. CROs
7.2.4.1. CROs Market, 2018 - 2030 (USD Million)
7.3. Hospitals
7.3.1. Hospitals Market, 2018 - 2030 (USD Million)
7.4. Academic Institutes
7.4.1. Academic Institutes Market, 2018 - 2030 (USD Million)
7.5. Clinical Testing Labs
7.5.1. Clinical Testing Labs Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Latin America Flow Cytometry Market Share By Region, 2022 & 2030
8.2. Latin America
8.2.1. SWOT Analysis
8.2.2. Latin America Flow Cytometry Market, 2018 - 2030 (USD Million)
8.2.3. Brazil
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. Brazil Flow Cytometry Market, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Key Country Dynamics
8.2.4.2. Target Disease Prevalence
8.2.4.3. Competitive Scenario
8.2.4.4. Regulatory Framework
8.2.4.5. Mexico Flow Cytometry Market, 2018 - 2030 (USD Million)
8.2.5. Argentina
8.2.5.1. Key Country Dynamics
8.2.5.2. Target Disease Prevalence
8.2.5.3. Competitive Scenario
8.2.5.4. Regulatory Framework
8.2.5.5. Argentina Flow Cytometry Market, 2018 - 2030 (USD Million)
8.2.6. Columbia
8.2.6.1. Key Country Dynamics
8.2.6.2. Target Disease Prevalence
8.2.6.3. Competitive Scenario
8.2.6.4. Regulatory Framework
8.2.6.5. Columbia Flow Cytometry Market, 2018 - 2030 (USD Million)
8.2.7. Peru
8.2.7.1. Key Country Dynamics
8.2.7.2. Target Disease Prevalence
8.2.7.3. Competitive Scenario
8.2.7.4. Regulatory Framework
8.2.7.5. Peru Flow Cytometry Market, 2018 - 2030 (USD Million)
8.2.8. Chile
8.2.8.1. Key Country Dynamics
8.2.8.2. Target Disease Prevalence
8.2.8.3. Competitive Scenario
8.2.8.4. Regulatory Framework
8.2.8.5. Chile Flow Cytometry Market, 2018 - 2030 (USD Million)
8.2.9. Uruguay
8.2.9.1. Key Country Dynamics
8.2.9.2. Target Disease Prevalence
8.2.9.3. Competitive Scenario
8.2.9.4. Regulatory Framework
8.2.9.5. Uruguay Flow Cytometry Market, 2018 - 2030 (USD Million)
8.2.10. Dominican Republic
8.2.10.1. Key Country Dynamics
8.2.10.2. Target Disease Prevalence
8.2.10.3. Competitive Scenario
8.2.10.4. Regulatory Framework
8.2.10.5. Dominican Republic Flow Cytometry Market, 2018 - 2030 (USD Million)
8.2.11. Costa Rica
8.2.11.1. Key Country Dynamics
8.2.11.2. Target Disease Prevalence
8.2.11.3. Competitive Scenario
8.2.11.4. Regulatory Framework
8.2.11.5. Costa Rica Flow Cytometry Market, 2018 - 2030 (USD Million)
8.2.12. Panama
8.2.12.1. Key Country Dynamics
8.2.12.2. Target Disease Prevalence
8.2.12.3. Competitive Scenario
8.2.12.4. Regulatory Framework
8.2.12.5. Panama Flow Cytometry Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. Cytiva
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. BD (Becton, Dickinson and Company)
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Sysmex Corporation
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Agilent Technologies, Inc.
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Apogee Flow Systems Ltd.
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Bio-Rad Laboratories, Inc.
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Thermo Fisher Scientific Inc.
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. DiaSorin S.p.A.
9.4.8.1. Overview
9.4.8.2. Product Benchmarking
9.4.8.3. Strategic Initiatives
9.4.9. Miltenyi Biotec
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Sartorius AG
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Funding by organizations
TABLE 4 Latin America Flow Cytometry Market, By Country, 2018-2030 (USD Million)
TABLE 5 Latin America Flow Cytometry Market, By Product, 2018-2030 (USD Million)
TABLE 6 Latin America Flow Cytometry Market, By Technology, 2018-2030 (USD Million)
TABLE 7 Latin America Flow Cytometry Market, By Application, 2018-2030 (USD Million)
TABLE 8 Latin America Flow Cytometry Market, By End-Use, 2018-2030 (USD Million)
TABLE 9 Brazil Flow Cytometry Market, By Product, 2018-2030 (USD Million)
TABLE 10 Brazil Flow Cytometry Market, By Technology, 2018-2030 (USD Million)
TABLE 11 Brazil Flow Cytometry Market, By Application, 2018-2030 (USD Million)
TABLE 12 Brazil Flow Cytometry Market, By End-Use, 2018-2030 (USD Million)
TABLE 13 Mexico Flow Cytometry Market, By Product, 2018-2030 (USD Million)
TABLE 14 Mexico Flow Cytometry Market, By Technology, 2018-2030 (USD Million)
TABLE 15 Mexico Flow Cytometry Market, By Application, 2018-2030 (USD Million)
TABLE 16 Mexico Flow Cytometry Market, By End-Use, 2018-2030 (USD Million)
TABLE 17 Argentina Flow Cytometry Market, By Product, 2018-2030 (USD Million)
TABLE 18 Argentina Flow Cytometry Market, By Technology, 2018-2030 (USD Million)
TABLE 19 Argentina Flow Cytometry Market, By Application, 2018-2030 (USD Million)
TABLE 20 Argentina Flow Cytometry Market, By End-Use, 2018-2030 (USD Million)
TABLE 21 Colombia Flow Cytometry Market, By Product, 2018-2030 (USD Million)
TABLE 22 Colombia Flow Cytometry Market, By Technology, 2018-2030 (USD Million)
TABLE 23 Colombia Flow Cytometry Market, By Application, 2018-2030 (USD Million)
TABLE 24 Colombia Flow Cytometry Market, By End-Use, 2018-2030 (USD Million)
TABLE 25 Peru Flow Cytometry Market, By Product, 2018-2030 (USD Million)
TABLE 26 Peru Flow Cytometry Market, By Technology, 2018-2030 (USD Million)
TABLE 27 Peru Flow Cytometry Market, By Application, 2018-2030 (USD Million)
TABLE 28 Peru Flow Cytometry Market, By End-Use, 2018-2030 (USD Million)
TABLE 29 Chile Flow Cytometry Market, By Product, 2018-2030 (USD Million)
TABLE 30 Chile Flow Cytometry Market, By Technology, 2018-2030 (USD Million)
TABLE 31 Chile Flow Cytometry Market, By Application, 2018-2030 (USD Million)
TABLE 32 Chile Flow Cytometry Market, By End-Use, 2018-2030 (USD Million)
TABLE 33 Uruguay Flow Cytometry Market, By Product, 2018-2030 (USD Million)
TABLE 34 Uruguay Flow Cytometry Market, By Technology, 2018-2030 (USD Million)
TABLE 35 Uruguay Flow Cytometry Market, By Application, 2018-2030 (USD Million)
TABLE 36 Uruguay Flow Cytometry Market, By End-Use, 2018-2030 (USD Million)
TABLE 37 Dominican Republic Flow Cytometry Market, By Product, 2018-2030 (USD Million)
TABLE 38 Dominican Republic Flow Cytometry Market, By Technology, 2018-2030 (USD Million)
TABLE 39 Dominican Republic Flow Cytometry Market, By Application, 2018-2030 (USD Million)
TABLE 40 Dominican Republic Flow Cytometry Market, By End-Use, 2018-2030 (USD Million)
TABLE 41 Costa Rica Flow Cytometry Market, By Product, 2018-2030 (USD Million)
TABLE 42 Costa Rica Flow Cytometry Market, By Technology, 2018-2030 (USD Million)
TABLE 43 Costa Rica Flow Cytometry Market, By Application, 2018-2030 (USD Million)
TABLE 44 Costa Rica Flow Cytometry Market, By End-Use, 2018-2030 (USD Million)
TABLE 45 Panama Flow Cytometry Market, By Product, 2018-2030 (USD Million)
TABLE 46 Panama Flow Cytometry Market, By Technology, 2018-2030 (USD Million)
TABLE 47 Panama Flow Cytometry Market, By Application, 2018-2030 (USD Million)
TABLE 48 Panama Flow Cytometry Market, By End-Use, 2018-2030 (USD Million)
TABLE 49 Company market share, 2022
List of Figures
Fig. 1 Market Research Process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Latin America Flow Cytometry Market Segmentation
FIG. 8 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 9 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 10 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 11 Penetration & Growth Prospect Mapping
FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Latin America flow cytometry market: Product outlook and key takeaways
FIG. 15 Latin America flow cytometry market: Product movement analysis & market share 2022 & 2030
FIG. 16 Instruments market, 2018-2030 (USD Million)
FIG. 17 Reagents & consumables market, 2018-2030 (USD Million)
FIG. 18 Software market, 2018-2030 (USD Million)
FIG. 19 Accessories market, 2018-2030 (USD Million)
FIG. 20 Services market, 2018-2030 (USD Million)
FIG. 21 Latin America flow cytometry market: Technology outlook and key takeaways
FIG. 22 Latin America flow cytometry market: Technology movement analysis & market share 2022 & 2030
FIG. 23 Cell-based market, 2018-2030 (USD Million)
FIG. 24 Bead-based market, 2018-2030 (USD Million)
FIG. 25 Latin America flow cytometry market: Application outlook and key takeaways
FIG. 26 Latin America flow cytometry market: Application movement analysis & market share 2022 & 2030
FIG. 27 Research market, 2018-2030 (USD Million)
FIG. 28 Industrial market, 2018-2030 (USD Million)
FIG. 29 Clinical market, 2018-2030 (USD Million)
FIG. 30 Latin America flow cytometry market: End-use outlook and key takeaways
FIG. 31 Latin America flow cytometry market: End-use movement analysis & market share 2022 & 2030
FIG. 32 Commercial organization market, 2018-2030 (USD Million)
FIG. 33 Hospitals market, 2018-2030 (USD Million)
FIG. 34 Academic institutes market, 2018-2030 (USD Million)
FIG. 35 Clinical testing labs market, 2018-2030 (USD Million)
FIG. 36 Latin America, SWOT Analysis
FIG. 37 Latin America
FIG. 38 Latin America Market Estimates And Forecast, 2018-2030 (USD Million)
FIG. 39 Brazil
FIG. 40 Brazil Market Estimates And Forecast, 2018-2030 (USD Million)
FIG. 41 Mexico
FIG. 42 Mexico Market Estimates And Forecast, 2018-2030 (USD Million)
FIG. 43 Argentina
FIG. 44 Argentina Market Estimates And Forecast, 2018-2030 (USD Million)
FIG. 45 Colombia
FIG. 46 Colombia Market Estimates And Forecast, 2018-2030 (USD Million)
FIG. 47 Peru
FIG. 48 Peru Market Estimates And Forecast, 2018-2030 (USD Million)
FIG. 49 Chile
FIG. 50 Chile Market Estimates And Forecast, 2018-2030 (USD Million)
FIG. 51 Uruguay
FIG. 52 Uruguay Market Estimates And Forecast, 2018-2030 (USD Million)
FIG. 53 Dominican Republic
FIG. 54 Dominican Republic Market Estimates And Forecast, 2018-2030 (USD Million)
FIG. 55 Costa Rica
FIG. 56 Costa Rica Market Estimates And Forecast, 2018-2030 (USD Million)
FIG. 57 Panama
FIG. 58 Panama Market Estimates And Forecast, 2018-2030 (USD Million)
FIG. 59 Strategy Mapping

Companies Mentioned

  • Cytiva
  • BD (Becton, Dickinson and Company)
  • Sysmex Corporation
  • Agilent Technologies, Inc.
  • Apogee Flow Systems Ltd.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • DiaSorin S.p.A.
  • Miltenyi Biotec
  • Sartorius AG

Methodology

Loading
LOADING...

Table Information